Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

131

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Mitochondrial metabolism and epigenetic crosstalk drive SASP

Mitochondrial metabolism and epigenetic crosstalk drive...

72

A holistic perspective on noninvasive brain– computer interfaces

A holistic perspective on noninvasive brain– computer i...

738

Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brain

Convergent molecular signatures across eating disorders...

67